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Accepted 5 July 2013Diabetes mellitus is an epidemic disease worldwide. Obesity is a
major risk factor for type 2 diabetes (T2DM). The goals of diabetic
care include minimizing long-term complications and avoiding
hypoglycemia. Lifestyle modiﬁcation aimed at reducing energy
intake and increasing physical activity is the principal therapy for
overweight and obese patients with T2DM.Moderateweight loss in
combinationwith increased activity can improve insulin sensitivity
and glycemic control. Overweight or obese patients should try to
achieve a gradual weight loss of 5e10% with a reduction in daily
caloric intake of 250e1000 kcal.
A 53-year-old woman, who was a dentist, was incidentally
found to have T2DM at a regular follow-up for breast cancer. She
had received a left mastectomy and chemotherapy at the age of 49
years. Her weight was 71.5 kg, height 154 cm, and body mass index
(BMI) 30.1 kg/m2. Her blood pressure was 118/78 mmHg. Serum
blood tests revealed that her fasting blood glucose was 303 mg/dL,
glycated hemoglobin level (A1C) 11.5%, serum creatinine level
1.0 mg/dL, low-density lipoprotein cholesterol 119 mg/dL, high-
density lipoprotein cholesterol 39 mg/dL, and triglycerides
130 mg/dL. She had no microalbuminuria, or micro- or macro-
vascular complications, and no family history of T2DM or cardio-
vascular disease.
An oral glucose-loweringmedication, glimepiride (Amaryl, 2mg
daily), was prescribed by a primary care physician. After consulta-
tion with her family physician about nonpharmacologic treatment,
she decided to modify her lifestyle. She discontinued drinking cola
and eating candy. Her daily intake was <1000 kcal, with a diet high
in ﬁber, low in fat, and low in carbohydrates. She tried to walkConﬂict of interest: none.
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http://dx.doi.org/10.1016/j.tcmj.2013.07.00330e45 minutes three times daily. She also actively monitored her
blood glucose and body weight at home. One month later, she
noticed that her fasting blood glucose level decreased to 100 mg/dL
or lower. Her medication was changed to metformin 500 mg twice
daily after consultation with her family physician.
With a low-calorie diet and moderate physical activity, her
weight decreased dramatically, by 8.4% in the 1st month and 6.1% in
the 2nd month. At the 3-month follow-up, she had lost 13 kg or
18.2% of her initial weight (Fig.1). Blood biochemistry tests revealed
that the patient reached the glycemic target of A1C 5.7% and low-
density lipoprotein cholesterol of 79 mg/dL. At the 6-month
follow-up, she had lost 25.2% of her initial weight and her BMI was
22.6 kg/m2. Although she regained weight gradually the following
year, her glycemic control was sustained (A1C < 6.0 %) (Fig. 2).Fig. 1. Changes in body weight and fasting blood glucose of an obese diabetes patient.
Foundation. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 2. Observation of BMI and glycemic level (A1C) over 2 years in an obese diabetic
patient with oral medication and lifestyle modiﬁcation. A1C ¼ glycated hemoglobin
level; BMI ¼ body mass index; GL ¼ glimepiride.
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within 2weekswith a low-dose oral medication. She lost 25% of her
body weight in 6 months, mainly through lifestyle modiﬁcation. An
active role by the patient is crucial in the management of chronic
diseases. Overweight or obese patients should be motivated to lose
weight through lifestyle modiﬁcation to improve diabetes care and
reduce medical costs. Strategies such as cognitive rational therapy
or shared decision making can be used after consultation.Further reading
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